The Living Guidelines: STEMI

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Cardiology Network

Discuss The Living Guidelines: STEMI further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Pharmacotherapy

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Beta Blocker Therapy [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for ACE Inhibitors Therapy

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Angiotensin Receptor Blockers Therapy

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIb [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Aldosterone Blockers Therapy

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIb [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Influenza Vaccination [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Reperfusion

Primary Invasive or Pharmacological Approach [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Facilitated PCI [1]

CLASS IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Immediate (or Emergency) Invasive Strategy and Rescue PCI [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion [1]

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Anticoagulants as Ancillary Therapy [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Anticoagulants for STEMI patients who do not undergo reperfusion therapy [1]

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Thienopyridines [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Reference

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Antman EM, Hand M, Armstrong PW, et al (January 2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078.



WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .